FDA approves first GMO Flu Vaccine containing Reprogrammed Insect Virus new vaccine for influenza has hit the market, and it is the first ever to contain genetically-modified (GM) proteins derived from insect cells. According to reports, the U.S. Food and Drug Administration (FDA) recently approved the vaccine, known as Flublok, which contains recombinant DNA technology and an insect virus known as baculovirus that is purported to help facilitate the more rapid production of vaccines.
FDA also approves flu vaccine containing dog kidney cells
Back in November, the FDA also approved a new flu vaccine known as Flucelvax that is actually made using dog kidney cells. A product of pharmaceutical giant Novartis, Flucelvax also does away with the egg cultures, and can similarly be produced much more rapidly than traditional flu vaccines, which means vaccine companies can have it ready and waiting should the federal government declare a pandemic.
Flublok, Flucelvax was made possible because of a $1 billion, taxpayer-funded grant given by the U.S. Department of Health and Human Services (HHS) to the vaccine industry back in 2006 to develop new manufacturing methods for vaccines.
more reads: https://nvicadvocacy.org/members/Home.aspx
FAIR USE NOTICE: These Videos/Articles may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior general interest in receiving similar information for research and educational purposes.
First Genetically Engineered Flu Vaccine Now on the Market
- To speed up flu vaccine production, the US FDA has approved a new insect-based, genetically engineered flu vaccine, as well as vaccines grown in cultures of dog kidney cells rather than eggs
- This year’s flu vaccine contains a very good match to the circulating strains, yet the reported efficacy of the vaccine is still only slightly over 60 percent
- In a wholly irresponsible move, some “health experts” are now proclaiming the conventional egg-based flu vaccine safe for those with severe egg allergies, and that the benefit of the flu vaccine (which this year has an official efficacy rating of about 60 percent) outweighs the potential risk of lethal anaphylaxis
- According to a recent review of published research, flu vaccines are ineffective at best, and produce neurological complications at worst, while having no effect at all on hospitalizations or working days lost. For infants, inactivated flu vaccine was found to have the same effectiveness as a placebo